Tuesday tips round-up: Unilever, Staffline, Sportech

5th Jan 2010 06:04

Unilever shares are trading on a December 2010 multiple of 17.4 and yielding 3.5pc. The company is well positioned in important emerging markets and the Telegraph's stance remains buy as the group's new strategy is starting to work.Staffline has been winning business recently and is detecting signs of life among its major clients. All this is good news and should keep things going nicely through the coming year. Even after recent rises, the shares are hardly expensive at just seven times' forecast full-year earnings. And while the prospective yield of 3.8 per cent is hardly stunning, the company does have a commendable policy of distributing its excess cash, so that could improve. But having had such a good run, the shares may suffer some profit-taking. So the Independent says hold for now but look to buy on any subsequent signs of weakness.Sportech shares, up ¼p to 48½p, are trading at only 3.5 times this year's earnings. That takes little account of Sportech's strong cashflows and growth opportunities. Buy, says the Times.Investors taking a punt on the sector might fancy a flutter on Lifeline. The Independent is impressed but also a little concerned that the stock already appears to trade at a premium to the sector. So hold on for the time being.Tomorrow's trading update from Majestic Wine should provide a welcome contrast to the travails suffered by the ill-fated Threshers group. Despite the still difficult economic backdrop, the company is expected to report robust like-for-like sales growth over the Christmas period, which accounts for a disproportionate slice of annual sales. With a long-term target of 250 stores, up from 153 currently, and with one of its big rivals now dead, Majestic's shares are worth holding, says the Times.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.